Updated Sources: Cedars-Sinai Prostate Cancer Experts Available to Explain Treatment, Prognosis
Following Former President Joe Biden's Prostate Cancer Diagnosis, Specialists On Hand to Answer Journalists' Questions
Cedars-Sinai prostate cancer experts are available for media interviews to explain former President Joe Biden's diagnosis and treatment options.
Experts include:
Robert Figlin, MD, interim director of Cedars-Sinai Cancer, the Steven Spielberg Family Chair in Hematology Oncology and Professor of Medicine and Biomedical Sciences. He can discuss novel cancer therapies as well as diagnosis and precision treatment.
Stephen Freedland, MD, Warschaw Robertson Law Families Chair in Prostate Cancer, can discuss the effectiveness of medication plus hormone therapy.
Hyung Kim, MD, chair of the Department of Urology and a practicing urologic oncologist, can discuss the physical and emotional health of patients with prostate cancer and treatment for the most challenging prostate cancer cases.
Edwin Posadas, MD, medical director of the Urologic Oncology Program, can discuss anti-androgen therapy to improve outcomes.
Howard Sandler, MD, chair of the Department of Radiation Oncology at Cedars-Sinai and can discuss combining radiotherapy and chemotherapy in prostate cancer treatment and novel radiation targeting strategies for prostate cancer. He can also discuss prostate cancer patients’ quality of life following surgery and radiation therapy.
Kristopher Wentzel, MD, hematologist-oncologist at The Angeles Clinic and Research Institute, an Affiliate of Cedars-Sinai, can explain immunotherapeutics and other novel targeted therapies.
Contact
To arrange interviews with Cedars-Sinai experts, contact Christina Elston at [email protected] or 626-298-0702.